Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients-Reference-Cited by-同舟云学术

Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients

Published:2001-04 Issue:1 Volume:21 Page:81-89
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Re M.C.,Vignoli M.,Furlini G.,Gibellini D.,Colangeli V.,Vitone F.,La Placa M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference43 articles.

1. The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells;Albini;Nat. Med.,1996

2. Identification of a novel domain of HIV tat involved in monocyte chemotaxis;Albini;J. Biol. Chem.,1998

3. Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides;Benelli;AIDS,1998

4. Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells;Borgatti;Eur. J. Immunol.,1997

5. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine;Cafaro;Nat. Med.,1999

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis;International Journal of Molecular Sciences;2024-01-30

2. Human Immunodeficiency Virus Vaccines;Plotkin's Vaccines;2023

3. HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine;Expert Review of Vaccines;2022-06-17

4. New insights into pathogenesis point to HIV-1 Tat as a key vaccine target;Archives of Virology;2021-08-14

5. Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines;Vaccines;2021-05-19